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hSpry2 Is Targeted to the Ubiquitin-Dependent
Proteasome Pathway by c-Cbl
ible antagonists of RTK signaling [1, 2]. Drosophila
Sprouty is a 63 kDa protein containing a cysteine-rich
domain within its C terminus that is highly conserved in
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the four mammalian Sprouty homologs (Spry 1–4). The1Department of Molecular Genetics and
N-terminal region of Sprouty proteins is highly divergent,Microbiology
with the exception of two small regions of similarity2 Graduate Program in Molecular and Cellular
between the Drosophila and mammalian proteins [1].Biology
One of these regions has been shown to bind to the3 Graduate Program in Genetics
ubiquitin ligase c-Cbl, a well-known negative regulatorState University of New York at Stony Brook
of RTK signaling [5]. c-Cbl mediates the multiubiquitina-Stony Brook, New York 11794-5222
tion of receptors such as the epidermal growth factor
receptor (EGFR), platelet-derived growth factor receptor
(PDGFR), and colony-stimulating factor 1 receptor (CSF-Summary
1R) and thereby targets them for degradation by the
proteasomal/lysosomal pathway [8–10]. It has beenSprouty was originally identified in a genetic screen
shown that the interaction of Spry2 with c-Cbl interferesin Drosophila as an antagonist of fibroblast (FGF) and
with the ability of c-Cbl to promote the ubiquitinationepidermal growth factor (EGF) signaling [1, 2]. Subse-
and degradation of the EGF receptor [5, 11, 12].quently, four vertebrate homologs were discovered;
Proteins that interact with c-Cbl are often found to beamong these, the human homolog Sprouty 2 (hSpry2)
ubiquitinated as a consequence of the ubiquitin ligasecontains the highest degree of sequence homology to
activity of c-Cbl. To determine whether the associationthe Drosophila protein [3, 4]. It has been shown that
between c-Cbl and hSpry2 leads to the ubiquitinationhSpry2 interacts directly with c-Cbl, an E3-ubiquitin
of hSpry2, we compared the abilities of ectopically ex-ligase, which promotes the downregulation of recep-
pressed hSpry2 and hSpry2-Cbl, a deletion mutanttor tyrosine kinases (RTKs) [5]. In this study, we have
lacking the c-Cbl binding region (residues 36–65), toinvestigated the functional consequences of the asso-
become ubiquitinated upon EGF stimulation. CHOK1ciation between hSpry2 and c-Cbl. We have found that
cells, which lack endogenous EGF receptor, were tran-
hSpry2 is ubiquitinated by c-Cbl in an EGF-dependent
siently transfected with expression vectors encoding
manner. EGF stimulation induces the tyrosine phos- EGFR, hemagglutinin (HA)-tagged ubiquitin, and HA-
phorylation of hSpry2, which in turn enhances the in- tagged hSpry2 constructs. As shown in Figure 1A, low
teraction of hSpry2 with c-Cbl. The c-Cbl-mediated levels of hSpry2 ubiquitination were detected in growth
ubiquitination of hSpry2 targets the protein for degra- factor-deprived cells. However, the addition of EGF in-
dation by the 26S proteasome. An enhanced pro- duced a significant increase in the ubiquitination of
teolytic degradation of hSpry2 is also observed in hSpry2, as indicated by the abundant presence of high
response to FGF stimulation. The FGF-induced degra- molecular weight HA-immunoreactive bands in the anti-
dation of hSpry2 limits the duration of the inhibitory hSpry2 immunoprecipitates. In contrast, the hSpry2-
effect of hSpry2 on extracellular signal-regulated ki- Cbl mutant, which does not associate with c-Cbl, was
nase (ERK) activation and enables the cells to recover not ubiquitinated either in the presence or in the absence
their sensitivity to FGF stimulation. Our results indicate of EGF (Figure 1B). These observations indicate that
that the interaction of hSpry2 with c-Cbl might serve as c-Cbl mediates the ubiquitination of hSpry2 in an EGF-
a mechanism for the downregulation of hSpry2 during dependent manner through its association with the
receptor tyrosine kinase signaling. amino-terminal region of hSpry2. The ability of c-Cbl to
ubiquitinate hSpry2 does not reflect a unique aspect of
Results and Discussion our experimental system, as similar results were ob-
tained by using COS-1 cells (data not shown). It is note-
EGF Stimulates the c-Cbl-Mediated Ubiquitination worthy that the enhanced ubiquitination of hSpry2 in
of hSpry2 response to EGF stimulation is accompanied by a de-
Signal transduction pathways that emanate from recep- crease in the levels of hSpry2 (Figure 1A). As discussed
tor tyrosine kinases (RTK) control various aspects of below, this decrease reflects the enhanced degradation
morphogenesis, patterning, cellular proliferation, and of hSpry2. We have observed that the immunoprecipi-
differentiation in both vertebrates and invertebrates [6]. tates of hSpry2 and hSpry2-Cbl both contain an HA-
It is now widely recognized that the spatial and temporal immunoreactive band of an apparent molecular weight
regulation of RTK signaling is accomplished by the inter- of 45 kDa that is present under both serum deprivation
and EGF stimulation conditions (Figures 1A and 1B). Theplay between negative and positive regulators [7].
identity of this band is presently unknown.Sprouty proteins comprise a conserved family of induc-
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Figure 1. c-Cbl Mediates the Ubiquitination of hSpry2 in an EGF-Dependent Manner
(A and B) CHOK1 cells were transiently transfected with expression vectors encoding the EGFR, HA-ubiquitin (Ub), and either (A) HA-hSpry2
or (B) HA-hSpry2-Cbl. A total of 24 hr posttransfection, the cells were serum starved for 16 hr and then incubated with () or without ()
EGF (100 ng/ml) for 10 min. Subsequently, the cells were lysed and analyzed by immunoprecipitation (IP) and Western blotting (Wb) with the
indicated antibodies. Each experiment shown is representative of at least three independent experiments.
the stimulation of hSpry2 ubiquitination by EGF might binding. CHOK1 cells were transfected with expression
vectors encoding EGFR and HA-hSpry2 or hSpry2Y55F,result from a growth factor-dependent increase in the
binding affinity between c-Cbl and hSpry2. To test this and endogenous c-Cbl was immunoprecipitated. As il-
lustrated in Figure 2C, hSpry2Y55F retained its abilityprediction, we compared the interaction between hSpry2
and c-Cbl in the presence and absence of EGF in CHOK1 to interact with c-Cbl, but, in contrast to the wild-type
hSpry2, this interaction was only slightly enhanced bycells that were transiently transfected with EGFR and
HA-tagged hSpry2. Consistent with earlier findings [5], EGF treatment. These results indicate that the phos-
phorylation of tyrosine 55 of hSpry2 contributes to thehSpry2 was able to constitutively interact with c-Cbl
(Figure 2A). Upon EGF addition, the interaction between regulation of the interaction between hSpry2 and c-Cbl.
Consistent with this interpretation, we have found thathSpry2 and c-Cbl was significantly enhanced (Figure
2A). Thus, the increase in the ubiquitination of hSpry2 c-Cbl-mediated ubiquitination of hSpry2Y55F after EGF
stimulation is attenuated (data not shown). In a recentseen after EGF stimulation may in part be mediated by
the EGF-induced increase in hSpry2-c-Cbl interaction. study, it has been shown that substitution of tyrosine
55 with alanine yields a dominant-negative mutant ofIt should be noted that the increase in the association
of hSpry2 with c-Cbl following EGF stimulation could hSpry2, which selectively enhances FGF-induced, but
not EGF-induced, MAP kinase activation [13]. The extentnot be detected when the levels of ectopically expressed
hSpry2 were high (data not shown). This may explain to which these effects can be attributed to changes in
c-Cbl binding remains to be determined.why a modulation of association between hSpry2 and
c-Cbl by growth factors was not detected in an earlier To examine the spatial relationship between hSpry2
and c-Cbl, we have analyzed the subcellular localizationstudy [5].
To identify the determinants within hSpry2 that are of ectopically expressed HA-hSpry2 and endogenous
c-Cbl in serum-starved and EGF-stimulated cells. Forresponsible for the EGF-dependent increase in its bind-
ing affinity toward c-Cbl, we focused our attention on this analysis, we have used COS-1 cells because endog-
enous c-Cbl is expressed in these cells at levels thata conserved tyrosine residue of hSpry2, tyrosine 55, that
is located within the c-Cbl binding region of hSpry2 [13]. are high enough to be detected by indirect immunofluo-
rescent staining. We have confirmed that the biochemi-To establish whether tyrosine 55 is phosphorylated upon
EGF stimulation, CHOK1 cells were transiently trans- cal features of the interaction between c-Cbl and hSpry2
in COS-1 cells are identical to those observed in CHOK1fected with the EGF receptor and HA-tagged hSpry2 or
an hSpry2 mutant in which tyrosine 55 was mutated cells (data not shown). As illustrated in Figure 2D, hSpry2
is associated predominantly with vesicular structuresto phenylalanine (hSpry2Y55F). As shown in Figure 2B,
hSpry2 became tyrosine phosphorylated in response to distributed throughout the cytoplasm both in EGF-
treated and untreated cells. A subpopulation of theEGF stimulation. In contrast, the hSpry2Y55F mutant
failed to undergo tyrosine phosphorylation upon EGF hSpry2-containing structures was found to colocalize
with the early endosome marker Rab5 [14], and thisstimulation (Figure 2B), suggesting that this residue is
critical for the EGF-induced tyrosine phosphorylation of finding suggests some degree of functional overlap be-
tween hSpry2 and the endocytic pathway (data nothSpry2.
Next, we utilized the hSpry2Y55F mutant to investi- shown). The vesicular pattern of hSpry2 subcellular dis-
tribution was observed in a number of different cellsgate the role of hSpry2 tyrosine phosphorylation in c-Cbl
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Figure 2. EGF Stimulation Enhances the Association of hSpry2 with c-Cbl
(A–C) Tyrosine phosphorylation of hSpry2 modulates the interaction with c-Cbl. CHOK1 cells were transiently transfected with expression
plasmids encoding the EGFR and either (A–C) HA-hSpry2 or (B and C) HA-hSpry2Y55F. Cells were starved and stimulated with EGF as
described in the legend of Figure 1. Subsequently, the cells were lysed and analyzed by immunoprecipitation (IP) and Western blotting (Wb)
with the indicated antibodies. Protein expression levels in whole-cell lysates (WCL) were determined by immunoblotting. The experiments
shown are representative of three independent experiments.
(D) Subcellular distribution of c-Cbl and HA-hSpry2. COS-1 cells transfected with hSpry2 were stimulated with EGF (100 ng/ml) for 15 min
and were processed for immunofluorescenet staining as described in the Supplementary Experimental Procedures (see the Supplementary
Material available with this article online). The cells were analyzed by laser scanning confocal microscopy to detect colocalization (yellow) of
HA-hSpry2 (green) and c-Cbl (red). Insert boxes show enlarged areas corresponding to specific examples of the extent of hSpry2/c-Cbl
colocalization. The scale bar represents 10 M.
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Figure 3. c-Cbl-Dependent Ubiquitination Stimulates the Degradation of hSpry2 by the 26S Proteasome Pathway
(A) CHOK1 cells were transiently transfected with expression plasmids encoding EGFR, HA-c-Cbl, and either HA-hSpry2 or HA-hSpry2-Cbl.
Serum starved cells were incubated with () or without () EGF as described in Figure 1.
(B) CHOK1 cells were transiently transfected with expression plasmids encoding EGFR, HA-c-Cbl, and HAM-hSpry2. Pulse-chase analysis of
hSpry2 stability was performed as described in the Supplementary Experimental Procedures. Where indicated, EGF (100 ng/ml) was added
to the chasing medium. Autoradiograms were quantified with a Storm Phosphor Imager (Molecular Dynamics).
(C) CHOK1 cells were transiently transfected with expression plasmids encoding the EGFR, HA-c-Cbl, and HA-hSpry2. A total of 24 hr
posttransfection, the cells were serum starved for 16 hr and were then treated with lactacystin (20 M), MG-132 (42 M), or DMSO as a
control for 2 hr. The cells were then stimulated with EGF (100 ng/ml) for 10 min in the presence or absence of lactacystin or MG-132.
(D) CHOK1 cells were transiently transfected with expression plasmids encoding the EGFR, HA-c-Cbl, and HA-hSpry2. A total of 24 hr
posttransfection, the cells were serum starved for 16 hr in the presence of NH4Cl (20 mM) or chloroquine (chloro) (100 M). The cells were
then stimulated with EGF (100 ng/ml) for 10 min in the presence of NH4Cl or chloroquine. For (A), (C), and (D), following EGF stimulation, the
cells were lysed and analyzed by immunoprecipitation (IP) and Western blotting (Wb) with the indicated antibodies. Protein expression levels
in whole-cell lysates (WCL) were determined by immunoblotting. For (A)–(D), the experiments shown are representative of three independent
experiments.
types (data not shown), and, for reasons that are pres- In agreement with published data [8], we have ob-
served that c-Cbl is present in small punctate cyto-ently unknown, it does not resemble the cytoskeletal/
membrane ruffles localization pattern of hSpry2 re- plasmic structures in nonstimulated cells but redistrib-
utes into a larger vesicular structures upon EGFported in an earlier study [15].
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Figure 4. The Effects of hSpry2 Proteolytic Degradation on FGF-Induced ERK Activation
(A) NIH3T3 cells were maintained in the presence () or absence () of doxycylin (Dox) to repress or induce, respectively, HA-hSpry2 expression.
Cells were serum starved for 12 hr and were treated with FGF-heparin (10–500 ng/ml) for the indicated intervals. Cell lysates were immunoblotted
with anti-phospho-ERK1/2 antibodies and anti-ERK1/2 antibodies.
(B) NIH3T3 cells maintained in the presence () or absence () of Dox were stimulated with FGF for the indicated intervals as described in
the legend of (A). Cell lysates were immunoblotted with anti-HA antibodies, and the relative intensities of the HA-hSpry2 bands were determined
by densitometry scanning and are presented as arbitrary units.
(C) NIH3T3 cells maintained in the presence () or absence () of Dox were stimulated with FGF for various intervals as described in the
Brief Communication
313
stimulation (Figure 2D). The presence of hSpry2 did not lysosomal pathway [18]. To determine which degrada-
tion pathway is engaged in the proteolytic degradationalter the subcellular distribution pattern of c-Cbl in non-
stimulated cells, and, under these conditions, only a of hSpry2 following EGF stimulation, we tested the effect
of the 26S proteasome inhibitors lactacystin and MG-small fraction of c-Cbl colocalized with hSpry2. In con-
trast, in EGF-stimulated cells, there was a significant 132 or the lysosomal inhibitors chloroquine and NH4Cl
on the levels of hSpry2. As shown in Figure 3C, the EGF-increase in the amount of c-Cbl associated with hSpry2-
containing structures (Figure 2D). This finding is consis- induced reduction in hSpry2 levels was abrogated in the
presence of both 26S proteasome inhibitors. However,tent with the biochemical data showing a ligand-depen-
dent increase in binding of c-Cbl to hSpry2 (Figure 2A). neither chloroquine nor NH4Cl prevented the degrada-
tion of hSpry2 following EGF stimulation (Figure 3D).The vesicular structures containing both hSpry2 and
c-Cbl were devoid of early or late endosomal markers Together, these observations indicate that c-Cbl-medi-
ated ubiquitination of hSpry2 targets hSpry2 to the pro-(data not shown). These observations suggest that the
interaction of c-Cbl with hSpry2 leads to the sequestra- teasomal degradation pathway. Since Drosophila Sprouty
has also been shown to interact with c-Cbl [5], it is likelytion of c-Cbl away from the endocytic pathway, which
might contribute to the capacity of hSpry2 to inhibit that the c-Cbl-directed ubiquitination and degradation
of Sprouty represents a conserved mechanism to modu-c-Cbl-mediated ubiquitination and degradation of the
EGF receptor described previously [11, 12]. late Sprouty’s function.
Genetic and biochemical studies indicate that Sprouty
is a component of a negative feedback loop that is setUbiquitinated hSpry2 Is Degraded
by 26S Proteasome Pathway up to downregulate RTK signaling [19]. Indeed, it has
been demonstrated that Sprouty expression induces theThe most commonly known function of ubiquitination is
to target proteins to the 26S proteasome for degradation attenuation or inhibition of ERK activation by several
RTKs [1, 2, 10, 13, 19–21]. Considering this mode of[16]. Since, the ubiquitination of hSpry2 is augmented
by EGF, one would predict that EGF stimulation would action, the ligand-dependent ubiquitination and degra-
dation of Sprouty might serve to limit the duration ofresult in the enhanced degradation of hSpry2. We have
observed that EGF stimulation was accompanied by a Sprouty activity, thereby allowing cells to regain respon-
siveness to RTK activation. To test this hypothesis, wereduction in the amount of hSpry2 (Figure 1A). In order
to confirm that the observed reduction is dependent on have investigated the consequences of hSpry2 degrada-
tion on the temporal pattern of FGF-induced ERK activa-the interaction of Sprouty with c-Cbl, CHOK1 cells were
transiently transfected with EGFR, HA-tagged c-Cbl, tion. The inhibitory effect of Sprouty on this signaling
pathway has been well documented both in Drosophilaand either HA-tagged hSpry2 or hSpry2-Cbl. As illus-
trated in Figure 3A, there was a significant decrease in and in mammalian cells [1, 3, 13, 21]. As an experimental
system, we have used NIH3T3 cells in which the expres-the amount of hSpry2 present in immunoprecipitates
derived from EGF-stimulated cells. In contrast, the levels sion of HA-hSpry2 is under the control of a tetracycline-
repressible activator and hence can be induced by theof hSpry2-Cbl were not altered by the addition of EGF,
indicating that c-Cbl interaction is required for the EGF- removal of doxycyclin from the growth medium (Figure
4B). In agreement with other reports [13, 21], the expres-induced reduction in hSpry2 abundance (Figure 3A).
To determine whether observed reduction of hSpry2 sion of HA-hSpry2 resulted in the attenuation of both the
intensity and duration of FGF-induced ERK activationlevels reflects the enhanced degradation of Sprouty, we
performed pulse-chase analysis. Because of the low (Figure 4A). This effect became apparent at 30 min after
FGF stimulation and persisted up to 2 hr after stimula-methionine content of hSpry2, we employed an expres-
sion vector in which hSpry2 is fused N-terminally to the tion. Concomitantly, the levels of HA-hSpry2 declined
and reached approximately 10% of the initial levels ofHAM tag, a methionine-rich variant of the HA tag [17].
CHOK1 cells were transiently transfected with EGFR, expression observed in the absence of FGF stimulation
within 2 hr of FGF stimulation (Figure 4B). To determinec-Cbl, and HAM-hSpry2. As shown in Figure 3B, in the
absence of EGF, hSpry2 levels were stable and re- whether the FGF-induced decrease in the amounts of
HA-hSpry2 reflects enhanced proteolytic degradation,mained unchanged during the chasing time. In contrast,
in EGF-treated cells, the half-life of hSpry2 decreased cells were stimulated with FGF in the presence or ab-
sence of MG-132. As illustrated in Figure 4C, the additionto25 min. Taken together, these data demonstrate that
EGF receptor activation accelerates the degradation of of MG-132 prevented to a large extent the FGF-induced
decrease in the levels of HA-hSpry2. The similarity be-hSpry2 and that this process depends on the ability of
hSpry2 to interact with c-Cbl. tween the protective effects of MG-132 on FGF- and
EGF-induced reduction in the amounts of HA-hSpry2Multiubiquitinated proteins are usually directed to the
26S proteasome pathway, although, in some cases, ubi- indicates that ligand-induced degradation of hSpry2
might be a common phenomenon shared by differentquitinated proteins are degraded by the endosomal/
legend of (A). Where indicated, MG-132 (42 M) was added to the culture medium 2 hr prior to the addition of FGF and was kept in the
medium throughout the time course of FGF stimulation.
(D) NIH3T3 cells were treated with MG-132 and were stimulated with FGF as described in the legend of (C). A total of 2 hr after the initial
stimulation with FGF (T  0), cells were stimulated again with FGF for 30 (T  30) and 60 (T  60) min, and ERK activity was determined by
immunoblotting of cell lysates with anti-phospho-ERK1/2 antibodies. The results in each panel are representative of at least two independent
experiments.
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